| Bid Price | 1628.00p | High Price | 1664.00p |
|---|
| Ask Price | 1630.00p | Low Price | 1626.00p |
|---|
| Open Price | 1657.00p | Spread | 0.12% |
|---|
| Prev Close | 1660.00p | Volume | 518,635 |
|---|
Hikma Pharmaceuticals PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Sep 11, 2025 | 1660.00 | 1672.00 | 1651.00 | 1660.00 | 599,461 |
| Sep 10, 2025 | 1691.00 | 1697.00 | 1662.00 | 1664.00 | 537,356 |
| Sep 9, 2025 | 1702.00 | 1709.00 | 1683.00 | 1691.00 | 1,050,725 |
| Sep 8, 2025 | 1724.00 | 1729.53 | 1686.00 | 1699.00 | 411,317 |
| Sep 5, 2025 | 1716.00 | 1734.00 | 1708.00 | 1720.00 | 1,130,248 |
Hikma Pharmaceuticals PLC Information
| Name | Hikma Pharmaceuticals PLC | Index | FTSE 100 |
|---|
| ISIN | GB00B0LCW083 | Epic | HIK |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | SET1 |
|---|
| Industry | Drug Manufacturers - Specialty & Generic | Sector | Healthcare |
|---|
| EMS | 500 | Trading Status | Closed |
|---|
| Shares in Issue | 221.45 m | Prev Close | 1660.00p |
|---|
| PE Ratio | 13.452355 | Market Cap | £3.61 bn |
|---|
| Div Yield | 3.84 | Div per Share | $0.48 |
|---|
| EPS | $1.07 | Div Cover | 2.2228 |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | 0.069322 | DPS Growth (%) | 0.2735 |
|---|
| Current Ratio | 1.243677 | Quick Ratio | 0.634728 |
|---|
Hikma Pharmaceuticals PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 22/08/25 | BUY | Laura Balan | NED | 3,500 @ £18.21 | £63,725.00 |
| 08/08/25 | BUY | Mazen Darwazah | CH | 200,000 @ £17.56 | £3,512,000.00 |
| 03/06/25 | TIN | Mazen Darwazah | CH | 36,171 @ £0.00 | £0.00 |
| 03/06/25 | TIN | Said Darwazah | CEO | 31,679 @ £0.00 | £0.00 |
| 03/06/25 | SELL | Riad Mishlawi | CEO | 13,863 @ £21.38 | £296,391.00 |
| 03/06/25 | TIN | Riad Mishlawi | CEO | 36,371 @ £0.00 | £0.00 |
| 08/05/25 | DRIP | Riad Mishlawi | CEO | 1,454 @ £20.23 | £29,414.00 |
| 04/03/25 | TIN | Mazen Darwazah | CH | 14,844 @ £0.00 | £0.00 |
| 04/03/25 | TIN | Said Darwazah | CEO | 18,420 @ £0.00 | £0.00 |
| 04/03/25 | EXR | Riad Mishlawi | CEO | 19,890 @ £0.00 | £0.00 |
Hikma Pharmaceuticals PLC News
